Emma Helstrom

Fox Chase Cancer Center

Papers

7

Total Citations

54

H-Index

5

About

No biography available yet.

Research Focus

Medicine7 · 54 citations
Urology7 · 54 citations
Internal medicine7 · 54 citations
Bladder cancer6 · 53 citations
Cancer6 · 53 citations
Urothelial carcinoma5 · 44 citations
Proportional hazards model2 · 26 citations
Surgery2 · 26 citations
Oncology4 · 18 citations
Hazard ratio1 · 17 citations
Propensity score matching1 · 17 citations
Confidence interval1 · 17 citations

Key Achievements

5
H-Index
7
Papers
54
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted nephroureterectomy: surgical and mid‐term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
17 citations · 2024
📈 Most Prolific Year: 2024 (5 Papers)
🤝 Key Collaborators: 77
🏛 Institutions: Fox Chase Cancer Center

Top Papers

  1. 1
    Robot‐assisted nephroureterectomy: surgical and mid‐term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)
    17 citations · 2024
  2. 2
    Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)
    10 citations · 2024
  3. 3
    The impact of bladder cuff excision on outcomes after nephroureterectomy for upper tract urothelial carcinoma: An analysis of the ROBUUST 2.0 registry
    9 citations · 2024
  4. 4
    Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry
    7 citations · 2024
  5. 5
    Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
    6 citations · 2024
  6. 6
    A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)
    4 citations · 2025
  7. 7
    Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node status
    1 citations · 2025

Key Collaborators

RMReza Mehrazin7 shared papersRBRaj Bhanvadia7 shared papersSRSoroush Rais‐Bahrami7 shared papersCPChandru P. Sundaram7 shared papersFSFarshad Sheybaee Moghaddam7 shared papersCYCourtney Yong7 shared papersHDHooman Djaladat7 shared papersMFMarco Finati7 shared papersSCSol C. Moon7 shared papersMLMark L. Gonzalgo7 shared papersFAFiras Abdollah7 shared papersRARiccardo Autorino6 shared papersAGAlireza Ghoreifi6 shared papersSPSisto Perdonà6 shared papersFDFrancesco Ditonno6 shared papersNSNirmish Singla6 shared papersAAAlessandro Antonelli6 shared papersDFDinno F. Mendiola6 shared papersIDIthaar Derweesh6 shared papersGTGabriele Tuderti6 shared papers
Not generated yet